Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension
Nicholas D Cober(University of Ottawa), Duncan J. Stewart(University of Ottawa), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Elmira Safaie Qamsari(Ottawa Hospital), Ke Yuan(Boston Children's Hospital), Timothy Klouda(Boston Children's Hospital), Rafael Soares Godoy(Ottawa Hospital), David P. Cook(University of Ottawa), Emma R. McCourt(Human Sciences Research Council), Jalil Azami(Ottawa Hospital), Yupu Deng(Ottawa Hospital), Ken Schlosser(Ottawa Hospital), Elham Salehisiavashani(Ottawa Hospital)
Cited by 7
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Wingless inactivates glycogen synthase kinase‐3 via an intracellular signalling pathway which involves a protein kinase C.
|The EMBO Journal|1996|387
Angiogenic Actions of Angiopoietin-1 Require Endothelium-Derived Nitric Oxide
|American Journal Of Pathology|2003|181
Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice
|Nature Neuroscience|2020|117
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73